After surprise trial failure, ALS doctors brace for one less treatment option
Bio Pharma Dive
MARCH 12, 2024
Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.
Let's personalize your content